Pan Cancer T raises funds through seed extension round
Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of preclinical studies for its leading product, PCT1:CO-STIM.
Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of preclinical studies for its leading product, PCT1:CO-STIM.
What's Your Reaction?
